Cargando…
High-Sensitivity Cardiac Troponin Publications during the COVID-19 Pandemic (2020–2022)
Autor principal: | Kavsak, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860561/ https://www.ncbi.nlm.nih.gov/pubmed/36661900 http://dx.doi.org/10.3390/jcdd10010005 |
Ejemplares similares
-
Combination of lymphocyte count and not the serological response with high-sensitivity cardiac troponin for risk stratification in patients with possible COVID-19
por: Kittanakom, Saranya, et al.
Publicado: (2021) -
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19
por: Kavsak, Peter A., et al.
Publicado: (2020) -
Incidence and Etiology of Poor Duplicate Ortho High-Sensitivity Cardiac Troponin I Results in a Community Hospital Emergency Department
por: Kavsak, Peter A., et al.
Publicado: (2022) -
Cardiovascular screening of athletes during the COVID-19 pandemic: The (ir)relevance of elevated cardiac troponins
por: Van De Heyning, Caroline M., et al.
Publicado: (2021)